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Introduction
Open surgical reconstruction of aortic arch pathologies, a 
complex surgery for arch aneurysms or dissections, remains 
to be associated with significant morbidity and mortality,1)2) 
as it often requires large incisions and cardiopulmonary by-
pass with risks of hemorrhage, stroke, renal impairment and 
paraplegia. 
Since Dake et al.3) reported the first thoracic endovascular 
aortic repair (TEVAR) in 1994, endovascular aortic repair tech-
nologies have rapidly evolved and are now more often recom-
mended than open reconstructions as a treatment for descend-
ing thoracic aortic pathologies. 
More complex endovascular techniques are required, how-
ever, when the arch vessels are involved in lesions, leaving an 
inadequate proximal or distal landing zone. In such cases, ad-
junctive open surgical bypasses can be utilized to provide ad-
equate landing zones and increase the feasibility of endovas-
cular repairs of thoracic aortic disorders. 
Hence, the ‘hybrid’ technique, which combines endovascu-
lar exclusion of aortic arch pathologies with an open surgical 
component, has recently been introduced in an attempt to tr-
eat complex cases with reduced morbidity and mortality.4)
The hybrid approach usually involves surgical “debranch-
ing” with various bypasses, such as carotid-subclavian, carot-
id-carotid and ascending aorta-innominate/carotid bypass, 
followed by a either concomitant or second-stage TEVAR.
In contrast to the conventional open arch repair, this hybrid 
procedure has potential advantages of avoiding or minimiz-
ing hypothermic circulatory arrest and cardiopulmonary by-
pass and reducing the perioperative morbidity and mortality. 
In addition, it is an alternative option for the patients with 
an aortic arch disease who were previously regarded a high 
risk group for conventional open repairs.
Endoleaks, however, remain as the primary limitation of en-
dovascular stent-grafting of the aortic aneurysm or dissection. 
Earlier reports on stent graft repairs of thoracic aortic aneu-
rysms have shown that endoleaks occurred in 5% to 20% of 
patients, which is comparable to rate of the incidences ob-
served after endovascular repair of abdominal aortic aneu-
rysm (EVAR).5-8) Hence, patients undergoing endovascular 
repair require careful and prolonged monitoring and-for some 
patients-there are needs for re-intervention. Generally, man-
agement has consisted of endovascular repair of type I or type 
III endoleaks, with observation of type II endoleaks.
As this hybrid approach has just begun, there is neither 
much information available on perioperative and long-term 
outcomes nor a single center that has gained significant op-
erative experiences in such a practice. 
In this issue of the Korean Circulation Journal, Kang et al.9) 
reported their experiences of employing the hybrid approach 
in patients with aortic arch pathologies. Although they con-
cluded that combining open reconstruction and endovascu-
lar repair for aortic arch pathologies was safe and effective with 
few complications, the study is limited by its retrospective 
design, a small sample size (n=7), the diversity of thoracic aor-
tic pathologies and a short follow-up duration. 
The hybrid approach to aortic arch disorders continues to 
evolve as stent-graft technology advances. Up to date, they 
have appeared to be favorable when adopted in selective high-
risk patients with a variety of thoracic aortic diseases. Total en-
dovascular approaches using custom-made fenestrated or br-
anched grafts are now at an early development stage and have 
been performed in certain specialized centers.10)11) With fur-
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ther innovation, total endovascular repair of complex aortic 
arch disorders may soon be feasible and TEVAR may become 
a preferable therapeutic option for most of the thoracic aor-
tic pathologies. 
As branched stent-grafts become more widely available 
for the aortic arch in the future, this hybrid arch procedure will 
likely to have further limitations in its role. Until then, how-
ever, the hybrid procedure may as well play an important role 
in treating patients with aortic arch diseases in a less invasive 
and potentially safer way. Further technological development 
and extensive clinical trials for long-term data are clearly need-
ed before widespread practice of this approach in lower risk pa-
tients.
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